Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| CDC-NCCDPHP-MM-0507 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Missouri-Columbia | OTHER |
| St. Louis University | OTHER |
The purpose of this study is to evaluate the health and arthritis-specific benefits of participation in the Arthritis Foundation People with Arthritis Can Exercise program and to collect information to improve community-based dissemination of this program.
Only about 24% of people with arthritis report sufficient physical activity to provide general health benefits. Research has demonstrated that many people with arthritis can safely exercise to improve fitness and health. The People with Arthritis Can Exercise (PACE) program, developed by the Arthritis Foundation, is a land-based recreational physical activity and exercise program. PACE has been offered as a community-based program for over 10 years and small studies have reported benefits for people with arthritis. However, there has been no randomized controlled community trials that evaluate the effectiveness of PACE in the community. The goals of the Evaluation of PACE project are to: (1) appropriately evaluate the AF PACE exercise program, and (2) provide information to support effective content, recruitment and programming. Specific objectives for meeting these goals include:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| People with Arthritis Can Exercise | Behavioral |
| Measure | Description | Time Frame |
|---|---|---|
| Physical Activity Level - PASE instrument at baseline, 8 and 16 weeks. | ||
| Pain Visual Analog Scale - at baseline, 8 and 16 weeks | ||
| Physical Function using the Functional Fitness Battery at baseline, 8 and 16 weeks | ||
| Self-reported function (HAQ) at baseline, 8 and 16 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Health-related quality of life | ||
| Disease status | ||
| Self-efficacy for arthritis management |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jennifer M Hootman, PhD | Centers for Disease Control and Prevention | Study Director |
| Marian Minor, PhD | University of Missouri-Columbia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St. Louis University | St Louis | Missouri | 63104 | United States |
Not provided
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D010003 | Osteoarthritis |
| D001172 | Arthritis, Rheumatoid |
| D009043 | Motor Activity |
| D010146 | Pain |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
| D003240 | Connective Tissue Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Self-efficacy for exercise |
| Social support |
| Depressive symptoms |
| Anxiety |
| D017437 |
| Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D001519 | Behavior |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |